| Literature DB >> 33333791 |
Federica Miressi1, Corinne Magdelaine1,2, Pascal Cintas3, Sylvie Bourthoumieux1,4, Angélique Nizou1, Paco Derouault5, Frédéric Favreau1,2, Franck Sturtz1,2, Pierre-Antoine Faye1,2, Anne-Sophie Lia1,2,5.
Abstract
Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of inherited disorders affecting the peripheral nervous system, with a prevalence of 1/2500. So far, mutations in more than 80 genes have been identified causing either demyelinating forms (CMT1) or axonal forms (CMT2). Consequentially, the genotype-phenotype correlation is not always easy to assess. Diagnosis could require multiple analysis before the correct causative mutation is detected. Moreover, it seems that approximately 5% of overall diagnoses for genetic diseases involves multiple genomic loci, although they are often underestimated or underreported. In particular, the combination of multiple variants is rarely described in CMT pathology and often neglected during the diagnostic process. Here, we present the complex genetic analysis of a family including two CMT cases with various severities. Interestingly, next generation sequencing (NGS) associated with Cov'Cop analysis, allowing structural variants (SV) detection, highlighted variations in MORC2 (microrchidia family CW-type zinc-finger 2) and AARS1 (alanyl-tRNA-synthetase) genes for one patient and an additional mutation in MFN2 (Mitofusin 2) in the more affected patient.Entities:
Keywords: CNV; Charcot–Marie–Tooth; NGS; diagnosis; multilocus disease
Year: 2020 PMID: 33333791 DOI: 10.3390/brainsci10120986
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425